MDLifespan and Cenegenics Partner to Expand Therapeutic Plasma Exchange Across the United States

CHICAGO (January 21, 2026) – MDLifespan, a physician-led medical technology company and certified Public Benefit Corporation, today announced a strategic partnership with Cenegenics, a global leader in age management and performance health medicine. Through this collaboration, MDLifespan will introduce its Advanced Serial Therapeutic Plasma Exchange (TPE) protocols within Cenegenics’ U.S. centers, expanding access to physician-led protocols designed to help address environmental toxin burden and inflammatory factors.

The national expansion will begin with initial markets in Los Angeles (Beverly Hills), California; Miami, Florida; and Atlanta, Georgia, with additional locations planned.

Rates of chronic inflammation and concern about environmental exposures continue to shape conversations around long-term health, including cognitive health, metabolic function, cardiovascular health, immune balance, and resilience.

While more people are investing in personalized nutrition, fitness, and preventive health strategies, environmental exposures remain an area of growing scientific and clinical interest. Toxins such as microplastics, PFAS, toxic metals, and pesticides can enter the body through food, water, air, and consumer products, prompting ongoing research into their potential effects on biological systems.

MDLifespan was founded to address this area through physician-led Advanced Therapeutic Plasma Exchange protocols designed to help evaluate and reduce circulating environmental toxin burden when clinically appropriate.

Cenegenics has spent decades helping patients pursue personalized health and performance goals through advanced diagnostics and physician-led programs.

By integrating MDLifespan’s Advanced Therapeutic Plasma Exchange protocols into its performance-health model, the partnership introduces an additional approach focused on evaluating environmental and inflammatory burden alongside existing health and longevity strategies.

“The future of longevity medicine requires that we not only optimize biology, but actively remove what is impairing it,” said Kristy Berry, CEO of Cenegenics. “Environmental toxins now represent a foundational driver of inflammation, metabolic dysfunction, and accelerated aging. This partnership allows us to introduce a proven, physician-led therapeutic solution that directly addresses that burden and elevating human performance care beyond optimization and into true biological restoration.”

The partnership represents an expansion of access to a therapy historically associated with hospital and specialty-care environments.

As interest in environmental exposure and inflammatory burden continues to grow, MDLifespan and Cenegenics are bringing serial Therapeutic Plasma Exchange into physician-led performance and longevity settings, alongside diagnostics, lifestyle strategies, and preventive health planning.

“This partnership reflects an important shift in how performance care is delivered,” said Dr. Paul Savage, Founder and Chief Medical Officer of MDLifespan. “Cenegenics focuses on optimizing the body’s systems. MDLifespan addresses the environmental and inflammatory burden that interferes with those systems. Together, we’re combining optimization with targeted toxin removal in a way that hasn’t been available at this scale.”

The initial Cenegenics locations in Beverly Hills, Miami, and Atlanta represent the first phase of the collaboration and are intended to expand geographic access to MDLifespan’s Advanced Serial Therapeutic Plasma Exchange protocols.

The partnership also reflects MDLifespan’s broader strategy of working with established physician-led practices to make structured TPE protocols available within clinical environments across the country.

Patients and physicians interested in learning more about MDLifespan’s Advanced Therapeutic Plasma Exchange protocols can explore the company’s educational resources and consultation options.

To learn more about MDLifespan or to schedule a consultation please visit www.mdlifespan.com/signup.

To explore Cenegenics’ personalized, physician-led approach to performance health and longevity, visit www.cenegenics.com.

Originally published via our press platform and republished in our official newsroom.